Evidence check: FOXO3 in the context of gut health

FOXO3 is a transcription factor primarily associated with longevity and cellular stress resistance. In the context of gut health, direct human evidence is limited. Mechanistically, FOXO3 may influence intestinal barrier function and inflammation via antioxidant pathways and NF-κB modulation. Animal studies suggest a role in maintaining gut homeostasis, e.g., by regulating tight junction proteins. However, robust clinical data linking FOXO3 variants to gut health outcomes in humans are lacking. The evidence is therefore preliminary and mainly mechanistic. Consumer DNA tests that highlight FOXO3 in relation to gut issues often overstate its predictive value. Without accompanying biomarkers or clinical symptoms, a standalone FOXO3 genotype is not actionable for gut health.